Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAstrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 12,050.00
Bid: 12,038.00
Ask: 12,040.00
Change: 0.00 (0.00%)
Spread: 2.00 (0.017%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 12,050.00
AZN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

UPDATE 3-Biden to send 20 mln doses of U.S.-authorized vaccines abroad for first time

Mon, 17th May 2021 18:00

(Updates with additional Biden quotes and details)

By Steve Holland

WASHINGTON, May 17 (Reuters) - President Joe Biden will send
at least 20 million more COVID-19 vaccine doses abroad by the
end of June, marking the first time the United States is sharing
vaccines authorized for domestic use.

The move marks a notable pivot from the White House as the
administration seeks to use the country's vaccine supply as a
diplomatic tool with the pandemic outlook brightening at home.

Biden announced on Monday that his administration will send
doses of the Pfizer Inc/BioNTech SE, Moderna
Inc and Johnson & Johnson vaccines, on top of
60 million AstraZeneca Plc doses he had already planned
to give to other countries.

Unlike the others, AstraZeneca's shot is not yet authorized
for use in the United States.

"Just as in World War Two America was the arsenal of
democracy, in the battle against COVID-19 pandemic our nation is
going to be the arsenal of vaccines," Biden said.

The president has been under pressure to share vaccines to
help contain worsening epidemics from India to Brazil, where
health experts fear new, more contagious coronavirus variants
could undermine the effectiveness of available shots.

Biden noted that no other country will send more vaccines
abroad than the United States. So far, the United Stages has
sent a few million AstraZeneca doses to Canada and Mexico.

"We want to lead the world with our values with this
demonstration of our innovation, ingenuity, and the fundamental
decency of American people," Biden said.

The White House has not provided any details about what
countries will receive the shots. Biden said that Jeff Zients,
who heads the U.S. vaccine efforts, will now also lead the
global vaccine push.

The United States has administered more than 272 million
COVID-19 vaccine doses and distributed more than 340 million,
according to federal data updated on Monday morning.

With more and more Americans vaccinated, U.S. deaths from
COVID-19 last week fell to their lowest in nearly 14 months,
while the number of new cases declined for a fifth consecutive
week, according to a Reuters analysis of state and county data.

Biden warned that those who do not get vaccinated "will end
up paying the price" as he lamented that "we're still losing too
many Americans" despite the significant progress.

(Reporting By Steve Holland, Carl O'Donnell and Jarrett
Renshaw; Writing by Jarrett Renshaw; Editing by Trevor Hunnicutt
and Bill Berkrot)

More News
16 Jan 2024 08:15

UBS downgrades AstraZeneca to 'sell'

(Sharecast News) - UBS has downgraded AstraZeneca and upgraded rival GSK as part of its latest review of the European pharmaceutical sector.

Read more
9 Jan 2024 10:50

Novartis in advanced talks to buy Cytokinetics- source

Jan 9 (Reuters) - Swiss drugmaker Novartis is in the lead to acquire Cytokinetics in a deal that could value the drug developer at well over $10 billion, a source familiar with the matter said on Monday.

Read more
8 Jan 2024 14:08

Late M&A bonanza stokes healthcare dealmakers ahead of JPMorgan conference

NEW YORK, Jan 5 (Reuters) - Healthcare dealmakers are making their way to San Francisco for a major industry conference, optimistic that more deals are in the offing after a wave of biotech company takeovers at the end of last year.

Read more
6 Jan 2024 17:44

Late M&A bonanza stokes healthcare dealmakers ahead of JPMorgan conference

NEW YORK, Jan 5 (Reuters) - Healthcare dealmakers are making their way to San Francisco for a major industry conference, optimistic that more deals are in the offing after a wave of biotech company takeovers at the end of last year.

Read more
5 Jan 2024 12:00

Late M&A bonanza stokes healthcare dealmakers ahead of JPMorgan conference

NEW YORK, Jan 5 (Reuters) - Healthcare dealmakers are making their way to San Francisco for a major industry conference, optimistic that more deals are in the offing after a wave of biotech company takeovers at the end of last year.

Read more
3 Jan 2024 17:48

London close: Stocks fall amid rising geopolitical concerns

(Sharecast News) - London stocks closed lower on Wednesday - the 40th anniversary of the FTSE 100's launch - as sentiment remained cautious due to increasing tensions in the Middle East.

Read more
3 Jan 2024 16:52

LONDON MARKET CLOSE: Stocks down ahead of US Fed minutes

(Alliance News) - Stock prices in London closed lower on Wednesday, as investors nervously look ahead to the latest US Federal Reserve meeting minutes.

Read more
3 Jan 2024 11:07

Jefferies upgrades GSK to 'buy', cuts AstraZeneca to 'hold'

(Sharecast News) - Jefferies has upgraded its rating on GlaxoSmithKline to 'buy' and cut AstraZeneca to 'hold' as part of its review of the European pharma sector.

Read more
3 Jan 2024 10:16

IN BRIEF: Nuformix narrows annual loss as develops drug assets

Nuformix PLC - London-based developer of treatments for fibrosis and oncology via drug repurposing - Pretax loss narrows to GBP927,972 in 18 months that ended September 30 from GBP1.3 million in the 12 months that ended March 31, 2022, following its change of financial year-end. Has no meaningful revenue in either period, so reduced loss is due to lower administrative expenses.

Read more
3 Jan 2024 10:12

AIM WINNERS & LOSERS: C4X gets Astra payment; Getech wins eight deals

(Alliance News) - The following stocks are the leading risers and fallers on AIM in London on Wednesday.

Read more
3 Jan 2024 09:23

LONDON BROKER RATINGS: GSK raised to 'buy'; AstraZeneca cut to 'hold'

(Alliance News) - The following London-listed shares received analyst recommendations Wednesday morning and Tuesday:

Read more
3 Jan 2024 08:58

LONDON MARKET OPEN: Stocks mixed pre-Fed minutes, amid Asia losses

(Alliance News) - Stock prices in London opened mixed on Wednesday, ahead of US Federal Reserve meeting minutes and manufacturing PMI data for the US in the evening and afternoon respectively.

Read more
3 Jan 2024 08:04

C4X receives USD11 million from AstraZeneca following NRF2 trials

(Alliance News) - C4X Discovery Holdings PLC on Wednesday said it has received payment from AstraZeneca PLC following trials of the C4X respiratory disease therapy treatment.

Read more
3 Jan 2024 07:54

LONDON BRIEFING: Stocks to open flat pre-Fed minutes, jobs data

(Alliance News) - The FTSE 100 is expected to open flat on Wednesday, as London's flagship index celebrates its 40th anniversary, after mostly downbeat trading in Asia and a tech sell-off in New York.

Read more
2 Jan 2024 17:05

British equities slip on higher yields, financials drag

FTSE 100 down 0.2%, FTSE 250 off 0.9%

*

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.